Tags: Ovarian Cancer, Cancer Treatment, Cancer Research, Cannabinoids, Minor Cannabinoids, CB2, TRPV2 receptor, Medical Cannabis, Science

Hinanit Koltai presents "The Anti-Cancer Activity of Cannabinoids Against Ovarian Cancer Involves the WNT Pathway" at CannMed 23.

0:00 Intro
4:17 Active compounds - in the female inflorescence
5:55 Ovarian Cancer
6:29 Cannabis Strains Active Against Ovarian Cancer
8:51 Receptors that may mediate cannabis activity against ovarian cancer
10:49 Activity against normal cells
11:00 Activity on patient’s cells
11:51 Effect on ovarian cancer tumors in vivo
12:58 The Wnt Pathway
16:20 Functional Tests
17:24 Cannabis Molecules to Drug Development
19:27 Acknowledgments
19:52 Q&A

To examine the effectiveness of combinations of cannabis compounds against ovarian cancer toward development of new cannabis-based medical products.

Cannabis sativa is widely used to alleviate numerous symptoms associated with medical conditions. Ovarian cancer (OC) is the most lethal gynecologic malignancy in the western world. Phytocannabinoids have been shown to have anticancer activity in a number of cancers, but only a few studies have examined the effectiveness of cannabis compounds against ovarian cancer.

Learn More about CannMed: https://cannmedevents.com/